Tenecteplase versus alteplase in treatment of acute ST-segment elevation myocardial infarction: A randomized non-inferiority trial

Tenecteplase versus alteplase in treatment of acute ST-segment elevation myocardial infarction: A randomized non-inferiority trial

Abstract. Background:. A phase II trial on recombinant human tenecteplase tissue-type plasminogen activator (rhTNK-tPA) has previously shown its preliminary efficacy in ST elevation myocardial infarction (STEMI) patients. This study was designed as a pivotal postmarketing trial to compare its effic...

Full description

Bibliographic Details
Main Authors: Xingshan Zhao, Yidan Zhu, Zheng Zhang, Guizhou Tao, Haiyan Xu, Guanchang Cheng, Wen Gao, Liping Ma, Liping Qi, Xiaoyan Yan, Haibo Wang, Qingde Xia, Yuwang Yang, Wanke Li, Juwen Rong, Limei Wang, Yutian Ding, Qiang Guo, Wanjun Dang, Chen Yao, Qin Yang, Runlin Gao, Yangfeng Wu, Shubin Qiao, Xiuyuan Hao
Format: Article
Language:English
Published: Wolters Kluwer 2024-02-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000002731

Internet

http://journals.lww.com/10.1097/CM9.0000000000002731

Similar Items